Evidence map›Paper›PMID 36823590›Full record

ArticleCell communication and signaling : CCS2023

Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress.

Marie Louise Ndzie Noah, Gabriel Komla Adzika, Richard Mprah, Adebayo Oluwafemi Adekunle, Stephane Koda, Joseph Adu-Amankwaah, Yaxin Xu, Kouminin Kanwore, Prosperl Ivette Wowui, Hong Sun

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Cell communication and signaling : CCS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. CK2α Deficiency Drives Myocardial Fibrosis via Desmin-Induced Mitochondrial Dysfunction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marie Louise Ndzie NoahDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Gabriel Komla AdzikaDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Richard MprahDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Adebayo Oluwafemi AdekunleDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Stephane KodaJiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Laboratory of Infection and Immunity, Xuzhou Medical University, Xuzhou, China.
Joseph Adu-AmankwaahDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Yaxin XuDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Kouminin KanworePublic Experimental Research Center, Department of Neurobiology and Anatomy, Xuzhou Medical University, Xuzhou, China.
Prosperl Ivette WowuiDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China.
Hong SunDepartment of Physiology, Xuzhou Medical University, 209 Tongshan Road, XuzhouJiangsu, 221004, China. sunh@xzhmu.edu.cn.
Xuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring myocardial damage, the sex hormone estrogen and CD73, the main enzyme that converts AMP into adenosine, are cardioprotective molecules. However, it is unclear how these two molecules work together to provide cardioprotection. The current study aimed to elucidate the interaction between estrogen and CD73 under chronic stress.

methodsOvariectomy and SHAM operations were done on FVB wild-type (WT) female mice. Two weeks after the operation, the mice were treated with daily isoproterenol (10 mg/kg/day) injections for 14 days. The effect of E2 on relevant cardiac injury biomarkers (BNP, ANP), myocardial morphology (cardiomyocyte surface area), electrocardiography, CD73 protein expression and activity, and macrophage (CD86 + and CD206 +) infiltrations were assessed. In vitro, H9C2 cells were treated with 1 nM of estrogen and 10 mM APCP (CD73 inhibitor α, β-methylene adenosine-5'-diphosphate), 10 µM isoproterenol and 20 µm LY294002 (PI3K inhibitor) for 24 h and western blot was done to elucidate the mechanism behind the effect of estrogen on the CD73/adenosine axis.

resultsEstrogen deficiency during chronic catecholamine stress caused myocardial injury, thereby triggering the hyperactivity of the CD73/adenosine axis, which aggravated myocarditis, adverse remodeling, and arrhythmias. However, estrogen normalizes CD73/Adenosine axis via the upregulation of PI3K/Akt pathways to prevent adverse outcomes during stress. In vivo results showed that the inhibition of PI3K significantly decreased PI3K/Akt pathways while upregulating the CD73/adenosine axis and apoptosis.

conclusionEstrogen's pleiotropy cardioprotection mechanism during stress includes its normalization of the CD73/Adenosine axis via the PI3K/Akt pathway. Video Abstract.

Indexed as

AdenosineMyocarditisAnimalsApoptosisArrhythmias, CardiacCatecholaminesEstrogensFemaleIsoproterenolMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAdenosineCatecholaminesEstrogensIsoproterenolPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAdenosineCardiac inflammationCatecholamine stressCD73Estrogen

Identifiers

PMID36823590
PMCPMC9948346
OpenAlexW4321597199

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.